Who is sponsoring NCT00394524?

NCT00394524 is sponsored by Emory University.

What condition does NCT00394524 study?

NCT00394524 studies Diabetes or With New Hyperglycemia.

What drugs are being tested in NCT00394524?

Interventions: Glucommander, Standard insulin infusion algorithm.

What is the status of NCT00394524?

NCT00394524 is currently COMPLETED.

Last reviewed 2018-10-02 · How we verify

Trial Between a Computer-Guided Intravenous Infusion Protocol Versus a Standard Insulin Infusion Algorithm in Medical ICU

NCT00394524 NA COMPLETED Results posted

The study is a multicenter, prospective, open-label randomized study to compare the safety and efficacy of continuous insulin infusion (CII) via a computer-guided(Glucommander) and a standard paper form protocol among the patients hospitalized in a medical intensive care unit (ICU). .

Details

Lead sponsor	Emory University
Phase	NA
Status	COMPLETED
Enrolment	160
Start date	2006-06
Completion	2008-09

Conditions

Diabetes or With New Hyperglycemia

Interventions

Glucommander
Standard insulin infusion algorithm

Primary outcomes

Mean Blood Glucose (BG) in mg/dl Among Glucommander Group Compared to Standard Insulin Infusion — First 10 days of ICU stay
Daily mean blood glucose concentrations during insulin infusion with the Glucommander and a standard paper form insulin infusion algorithm are measured every day up until 10 days and a mean values of these levels are calculated. The Mean blood glucose concentrations are measured once the target blood glucose levels are achieved after admission

Countries

United States